https://ift.tt/eA8V8J Scientists have developed a new type of 'double-bridged peptide' that can be tailored to bind tightly to disease targets of interest. The peptides' highly efficient binding, combined with their small size and high stability make them ideal for drug therapies.
from https://ift.tt/2I1FMnL
via IFTTT
#1 Drug Treatment Center. Expert Medical Detox· Privacy & Safety · Caring & Compassionate CALL NOW 844-463-1889
GET HELP NOW
Subscribe to:
Post Comments (Atom)
Children whose mothers use marijuana are more likely to try it at younger age
When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...
-
http://ift.tt/eA8V8J Researchers have shown that virtual particles known as skyrmions, discovered just a few years ago, hold promise as a ne...
-
https://t.co/3RQWlkdPjz #cnn #cnnbrk #lomasvisto — blogthis (@blogthisco) August 17, 2017 from Twitter https://twitter.com/blogthisco...
-
http://ift.tt/eA8V8J Health scientists have heralded the discovery of a gene associated with lung fibrosis as 'a potential new avenue of...
No comments:
Post a Comment